Clinical validation study of a novel prognostic risk prediction model (CHIP Score) for interventional therapy in patients with NSTE-ACS-a single-center retrospective cohort study based on 348 patients.

ABSTRACT:

Background

A complex high-risk indicated percutaneous coronary intervention (CHIP) score was recently developed from the British Cardiovascular Intervention Society (BCIS) database to define CHIP cases and their risk of in-hospital major adverse cardiac or cerebrovascular events (MACCE). However, the effectiveness and reliability of this model in predicting the risk of MACCE in CHIP patients after discharge require further validation.This study aims to clinically validate the prognostic value of the CHIP Score in patients with NSTE-ACS undergoing PCI.

Methods

In this study, a total of 348 patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) who underwent percutaneous coronary intervention (PCI) at the People's Hospital of Ningxia Hui Autonomous Region from Janua

SUBMITTER: Zhu Q 

PROVIDER: S-EPMC12870313 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature